Carmot Strategic has served as consultant to major pharmaceutical companies and to PhRMA, the premier U.S. pharmaceutical association. Engaging at the CEO level, Carmot’s advisory role has ranged across issues critical to the industry’s ongoing advancement, from innovation and incentivization to R&D promotion and patent protection policies.

At present, Carmot is engaged as strategic issue advisor with TaitLabs, a North American biotech company focused on developing innovative health solutions that combine modern science and traditional medicines.

Practice Areas

Recent News

Investor’s Business Daily

Road to Somewhere
April 10, 2017

Real Clear World

Daniel McGroarty Testifies Before U.S. Senate
January 19, 2016

Wall Street Journal

Miners Struggle With a Federal Cave-In
July 24, 2014